Figure 2.
TGA peak height of blood samples from patients with hemophilia A under the following conditions: (A) PPP, (B) PPP+CTI, (C) PRP, and (D) PRP+CTI. CTI, corn trypsin inhibitor; PPP; platelet‐poor plasma, PRP; platelet‐rich plasma, TGA, thrombin generation assay